|
| 36787750 | Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity. | Neuron | 2023 |
| 33510605 | A Fiber Alginate Co-culture Platform for the Differentiation of mESC and Modeling of the Neural Tube. | Front Neurosci | 2021 |
| 32321192 | Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice. | Br J Pharmacol | 2020 |
| 32053110 | The proposed mechanisms of action of CBD in epilepsy. | Epileptic Disord | 2020 |
| 31989581 | Anabolic androgenic steroid abuse in the United Kingdom: An update. | Br J Pharmacol | 2020 |
| 31693171 | A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models. | Br J Pharmacol | 2020 |
| 33089780 | Cannabidiol interactions with voltage-gated sodium channels. | Elife | 2020 |
| 32656346 | Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent. | Cannabis Cannabinoid Res | 2020 |
| 29457829 | Species-specific susceptibility to cannabis-induced convulsions. | Br J Pharmacol | 2019 |
| 31277369 | The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca<sup>2+</sup>-Activated K<sup>+</sup> Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing. | Pharmaceuticals (Basel) | 2019 |
| 31035309 | Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol. | J Cachexia Sarcopenia Muscle | 2019 |
| 30588604 | Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models. | Epilepsia | 2019 |
| 28190239 | Evaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous System. | Mol Neurobiol | 2018 |
| 25712225 | Human neural stem cell-derived cultures in three-dimensional substrates form spontaneously functional neuronal networks. | J Tissue Eng Regen Med | 2017 |
| 28485896 | Sonic hedgehog signalling mediates astrocyte crosstalk with neurons to confer neuroprotection. | J Neurochem | 2017 |
| 28108584 | Astrocytic transporters in Alzheimer's disease. | Biochem J | 2017 |
| 28190698 | Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection. | Epilepsy Behav | 2017 |
| 28125508 | A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9-tetrahydrocannabinol, elicits hyperphagia in rats. | Behav Pharmacol | 2017 |
| 28120231 | Molecular Pharmacology of Phytocannabinoids. | Prog Chem Org Nat Prod | 2017 |
| 28888969 | mTOR-related neuropathology in mutant tsc2 zebrafish: Phenotypic, transcriptomic and pharmacological analysis. | Neurobiol Dis | 2017 |
| 27646129 | The neurogenesis of P1 and N1: A concurrent EEG/LFP study. | Neuroimage | 2017 |
| 26847743 | Nuclear accumulation of myocyte muscle LIM protein is regulated by heme oxygenase 1 and correlates with cardiac function in the transition to failure. | J Physiol | 2016 |
| 26439367 | Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea. | Psychopharmacology (Berl) | 2016 |
| 27930653 | Characterisation of Development and Electrophysiological Mechanisms Underlying Rhythmicity of the Avian Lymph Heart. | PLoS One | 2016 |
| 27608434 | The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats. | Epilepsy Res | 2016 |
| 27503475 | Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. | Psychopharmacology (Berl) | 2016 |
| 27317835 | Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor. | Physiol Behav | 2016 |
| 27545646 | Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat. | Br J Pharmacol | 2016 |
| 26909803 | A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat. | PLoS One | 2016 |
| 25484265 | Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses. | Eur J Neurosci | 2015 |
| 26334724 | Cannabinoids in the Treatment of Neurological Disorders. | Neurotherapeutics | 2015 |
| 26264914 | Molecular Targets of Cannabidiol in Neurological Disorders. | Neurotherapeutics | 2015 |
| 26400260 | Erratum to: Cannabinoids in the Treatment of Neurological Disorders. | Neurotherapeutics | 2015 |
| 26493605 | Neuronal-glial populations form functional networks in a biocompatible 3D scaffold. | Neurosci Lett | 2015 |
| 26282273 | Cannabinoids and Epilepsy. | Neurotherapeutics | 2015 |
| 23897801 | Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. | Phytother Res | 2014 |
| 25029033 | Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. | ACS Chem Neurosci | 2014 |
| 24854329 | Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. | Epilepsia | 2014 |
| 24642454 | Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. | Neurosci Lett | 2014 |
| 24666107 | Effects and mechanisms of ginseng and ginsenosides on cognition. | Nutr Rev | 2014 |
| 23530974 | Endogenous cholinergic tone modulates spontaneous network level neuronal activity in primary cortical cultures grown on multi-electrode arrays. | BMC Neurosci | 2013 |
| 24282673 | Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression. | PeerJ | 2013 |
| 24134851 | Curcumin protects organotypic hippocampal slice cultures from Aβ1-42-induced synaptic toxicity. | Toxicol In Vitro | 2013 |
| 23860329 | CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. | Epilepsy Res | 2013 |
| 23902406 | Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. | Br J Pharmacol | 2013 |
| 23732642 | The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CBâ¿ receptor-mediated signalling. | J Physiol | 2013 |
| 21924288 | Phytocannabinoids as novel therapeutic agents in CNS disorders. | Pharmacol Ther | 2012 |
| 22970845 | Cannabidivarin is anticonvulsant in mouse and rat. | Br J Pharmacol | 2012 |
| 22520455 | Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. | Seizure | 2012 |
| 22543671 | Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. | Psychopharmacology (Berl) | 2012 |